Myagen (Bolasterone): The Potent & Toxic Mass Builder

Introduction: The Compound's Identity

Myagen, the trade name for Bolasterone, is an exceptionally potent oral anabolic steroid that is a derivative of Methyltestosterone. It is structurally Methyltestosterone with an added methyl group at the 7-alpha position, which dramatically amplifies its anabolic and androgenic potency. On paper, it has an anabolic rating of 575 and an androgenic rating of 225. In practice, Bolasterone is an incredibly powerful mass and strength-building agent, often compared to a combination of Dianabol and Anadrol but with even greater potency per milligram. Its immense power is matched by its extreme toxicity, particularly to the liver, classifying it as a high-risk compound for very short-term use by only the most advanced and knowledgeable athletes.

I. Mechanism of Action: How It Works

Bolasterone's extreme effects are a result of its unique di-methylated structure.

• Potent Androgen Receptor Binding: The 7-alpha methyl group significantly enhances its binding affinity to the androgen receptor, driving massive increases in protein synthesis and nitrogen retention. This leads to very rapid and dramatic muscle hypertrophy.

• Aromatization: Like its parent compound, Methyltestosterone, Bolasterone aromatizes into a highly potent form of estrogen. This contributes significantly to its mass-gaining effects but also to severe estrogenic side effects like water retention.

• Hepatotoxicity (C17-AA): It is a C17-alpha alkylated steroid, making it orally bioavailable but also placing significant strain on the liver. The additional 7-alpha methyl group is believed to exacerbate this hepatotoxicity.

II. Benefits: What to Expect

Myagen is known for producing explosive, "wet" gains in size and strength, surpassing many other common orals.

• Scientific Findings: Bolasterone had very brief and limited medical use before being discontinued due to its severe side effect profile. As such, modern clinical data is virtually non-existent, and knowledge is almost entirely derived from historical data and anecdotal user reports.

• Anecdotal Reports (User Consensus):

  • Explosive Mass & Weight Gain: Users report extremely rapid and substantial gains in weight and muscle size, often exceeding those of Dianabol or Anadrol at equivalent doses. A significant portion of this is water retention, creating a very full but "bloated" look.

  • Immense Strength Increases: It is considered one of the most powerful strength-enhancing orals ever created. Users report dramatic increases in raw power almost immediately.

  • Powerful Sense of Well-being: A very strong "on" feeling, characterized by confidence, aggression, and an enhanced sense of well-being, is commonly reported, similar to other potent mass builders.

III. Forms, Esters, and Half-Life: Administration Protocols

Myagen is an oral C17-alpha alkylated (C17-AA) steroid.

• Form: Oral tablet.

• Half-Life: Relatively short, estimated to be around 6-8 hours.

• Administration: Due to its short half-life, the total daily dose must be split into multiple administrations (at least 2-3 times per day) to maintain stable blood plasma levels.

IV. Performance Dosages: Practical Application

Due to its extreme potency and toxicity, Bolasterone dosages must be kept very low and for exceptionally short durations.

• Medical Dosages: There are no current medical uses.

• Anecdotal Performance Doses (User Consensus):

  • Standard Dose: A common dose range is just 1-3mg per day. Doses above 5mg per day are considered extremely high and reckless, dramatically increasing the risk of severe side effects.

  • Cycle Lengths: Due to its profound hepatotoxicity, Bolasterone cycles must be kept extremely short, typically 2-4 weeks maximum. It is used as a very potent kickstart to a cycle.

V. Managing Side Effects: Navigating Risks

Myagen has an extremely severe and multifaceted side effect profile. It is considered one of the harshest steroids ever made.

A. Estrogenic Side Effects

• Mechanism: It aromatizes into a very potent estrogen.

• Risks: This is a major and severe concern. Rapid and severe water retention, extreme bloating ("moon face"), very high risk of aggressive gynecomastia, and dangerous elevations in blood pressure are extremely common, even at low doses.

• Management (Anecdotal):

  • Aromatase Inhibitors (AIs): A potent AI like Arimidex or Letrozole is considered absolutely essential from day one to have any hope of controlling the severe estrogenic effects.

  • Selective Estrogen Receptor Modulators (SERMs): A SERM like Nolvadex is often kept on hand as a secondary defense against gynecomastia.

B. Androgenic Side Effects

• Risks: Despite its on-paper rating, it is a very potent androgen. Severe acne, oily skin, and rapid male pattern baldness in those predisposed are high risks. Virilization in women is so extreme that it is absolutely contraindicated for any female use.

• Management: 5-alpha reductase inhibitors are ineffective.

C. Cardiovascular Concerns

• Impact: This is an extreme risk. The combination of severe water retention, dangerously high blood pressure, and a profoundly negative impact on cholesterol (crushing HDL, raising LDL) makes it one of the most cardiotoxic steroids available.

• Anecdotal: Daily blood pressure monitoring is non-negotiable. The cardiovascular strain is often immediate and severe.

D. Hepatotoxicity (Liver Toxicity)

• Risks: As a di-methylated C17-alpha alkylated oral steroid, Myagen is unbelievably hepatotoxic. It is widely considered to be one of the single most liver-toxic oral steroids ever created, on par with or even exceeding Methyl Tren.

• Management: Cycle lengths must be extremely short (2-4 weeks max). Complete abstinence from alcohol is mandatory. The most potent, high-dose liver support supplements available, such as TUDCA, are considered absolutely essential.

VI. HPTA Shutdown and Post-Cycle Therapy (PCT)

Myagen is profoundly and immediately suppressive to the Hypothalamic-Pituitary-Testicular Axis (HPTA).

• Suppression: It will cause a complete and near-instantaneous shutdown of endogenous testosterone production.

• PCT Protocols (Anecdotal Consensus):

  • Timing: PCT can be initiated 12-24 hours after the last dose.

  • Protocol: An extremely robust and aggressive PCT protocol is essential. This will involve hCG followed by a lengthy and high-dose course of both Clomid and Nolvadex.

VII. Harm Reduction & Sourcing Considerations

• Blood Monitoring: Absolutely mandatory. Comprehensive panels must include liver enzymes (ALT, AST, GGT, Bilirubin) and a full lipid panel (HDL/LDL). Daily blood pressure monitoring is mandatory.

• Specific Use Case: Myagen is an extreme, high-risk, short-term bulking agent. It has no place in the arsenal of a beginner, intermediate, or even most advanced users due to its horrific side effect profile.

• Extreme Rarity & Sourcing: Bolasterone is exceptionally rare and has not been produced legitimately for decades. The likelihood of finding a genuine product on the UGL market is virtually zero. Any product labeled "Myagen" or "Bolasterone" is almost certainly a counterfeit, likely containing a cheaper, more common oral like Dianabol or Anadrol.

• Verification: Third-party lab testing is non-negotiable. Given the extreme toxicity and near-certainty of it being a fake, using an unverified "Myagen" product is an exceptionally dangerous and pointless gamble.